Rare diseases
Investigational molecules
Locations
Study on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation
PolandStudy on Efruxifermin for Patients with Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) or Metabolic Dysfunction-Associated Steatohepatitis (MASH)
PolandA Study of Baricitinib to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes
PolandLong‑Term Safety and Efficacy Study of Danicamtiv in Adults with Symptomatic Genetic and Familial Dilated Cardiomyopathy
PolandPhase 3 Extension Trial Evaluating Long‑Term Efficacy, Safety and Tolerability of maridebart cafraglutide in Adults with Obesity
PolandLong‑term Efficacy, Safety and Tolerability of maridebart cafraglutide in Adults with Obesity and Type 2 Diabetes
PolandRamantamig (JNJ-79635322) with drug combination versus standard therapy in newly diagnosed multiple myeloma patients not eligible for stem cell transplant
PolandEfficacy and safety of osilodrostat with drug combination in patients with hypertension caused by Cushing's syndrome
PolandFirst‑line Study of RMC‑9805 with Investigator’s Choice Chemotherapy Drug Combination vs Chemotherapy Alone in Patients with Metastatic KRAS G12D‑Mutated Pancreatic Adenocarcinoma
PolandA Phase 3 Study of Sapablursen Compared with Placebo in Adults with Polycythemia Vera
PolandPhase 3 study comparing linvoseltamab and daratumumab in high‑risk smoldering multiple myeloma patients
PolandEfficacy and safety of ABP 938 compared with aflibercept in participants with neovascular age‑related macular degeneration
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
